Simultaneous occurrence of fibrillary glomerulopathy and AL amyloid.
Dussol
B
B
Service de Néphrologie, Hôpital Sainte-Marguerite, Marseille, France.
Kaplanski
G
G
Daniel
L
L
Brunet
P
P
Pellissier
J F
JF
Berland
Y
Y
D000682:Amyloid / Q000378:metabolism*; D000686:Amyloidosis / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D001706:Biopsy; D002699:Chlorambucil / Q000627:therapeutic use; D005500:Follow-Up Studies; D005921:Glomerulonephritis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006977:Hypertension, Renal / Q000188:drug therapy / Q000209:etiology; D007075:Immunoglobulin M / Q000097:blood; D007678:Kidney Glomerulus / Q000648:ultrastructure; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D008258:Waldenstrom Macroglobulinemia / Q000150:complications / Q000188:drug therapy
D000682:Amyloid; D018906:Antineoplastic Agents, Alkylating; D005938:Glucocorticoids; D007075:Immunoglobulin M; C035222:amyloid protein AL; D002699:Chlorambucil; D011241:Prednisone